Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 26, Number 4—April 2020
Research

Intensified Short Symptom Screening Program for Dengue Infection during Pregnancy, India

Shilpa NaikComments to Author , Matthew L. Robinson, Mallika Alexander, Ajay Chandanwale, Pradip Sambarey, Aarti Kinikar, Renu Bharadwaj, Gajanan N. Sapkal, Puja Chebrolu, Prasad Deshpande, Vandana Kulkarni, Smita Nimkar, Vidya Mave, Amita Gupta, and Jyoti Mathad
Author affiliations: Byramjee Jeejeebhoy Government Medical College and Sassoon General Hospitals, Pune, India (S. Naik, A. Chandanwale, P. Sambarey, A. Kinikar, R. Bharadwaj); Johns Hopkins School of Medicine, Baltimore, Maryland, USA (M.L. Robinson, A. Gupta); Byramjee Jeejeebhoy Government Medical College–Johns Hopkins Clinical Trials Unit, Pune (M. Alexander, P. Deshpande, V. Kulkarni, S. Nimkar, V. Maye); National Institute of Virology, Pune (G.N. Sapkal); Weill Cornell Medical College, New York, New York, USA (P. Chebrolu, J. Mathad)

Main Article

Table 2

Trioplex and standard of care test results during intensified short symptom screening program for dengue infection during pregnancy, India

Trioplex results
 Standard of care results
Dengue positive, n = 7 1 rapid diagnostic negative, 1 IgM positive, 5 not tested
Dengue negative, n = 42 1 rapid diagnostic negative, 1 IgM positive, 40 not tested

Main Article

Page created: March 17, 2020
Page updated: March 17, 2020
Page reviewed: March 17, 2020
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external